Crossref
Rh1 Abolishes MCF-7 Cell Growth via Down-Regulation of ROS-Induced PKCδ/p38/ERK1/2 Signaling Pathway
Drug Targets and Therapeutics · 2022
DOI: 10.58502/dtt.22.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Targets and Therapeutics, 2022. Verfasst von Diem Thi Ngoc Huynh und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Huynh, D. T. N., & Heo, K. (2022). Rh1 Abolishes MCF-7 Cell Growth via Down-Regulation of ROS-Induced PKCδ/p38/ERK1/2 Signaling Pathway. Drug Targets and Therapeutics. https://doi.org/10.58502/dtt.22.009
Vancouver
Huynh DTN, Heo K. Rh1 Abolishes MCF-7 Cell Growth via Down-Regulation of ROS-Induced PKCδ/p38/ERK1/2 Signaling Pathway. Drug Targets and Therapeutics. 2022. doi:10.58502/dtt.22.009
BibTeX
@article{Huynh2022,
author = {Huynh, Diem Thi Ngoc and Heo, Kyung-Sun},
title = {Rh1 Abolishes MCF-7 Cell Growth via Down-Regulation of ROS-Induced PKCδ/p38/ERK1/2 Signaling Pathway},
journal = {Drug Targets and Therapeutics},
year = {2022},
doi = {10.58502/dtt.22.009}
}
EUVIMED